Income tax expense · 2013–2025
Elite Pharmaceuticals income tax expense
$11.9M+180.2% · FY2025
Elite Pharmaceuticals (ELTP) reported $11.9M in income tax expense for fiscal 2025, +180.2% year on year.
| Fiscal year | Income tax expense | Change | Filing |
|---|---|---|---|
| FY20252026-03-31 | $11.9M | +180.2% | Open → |
| FY20242025-03-31 | $4.3M | +$23.9M | Open → |
| FY20232024-03-31 | −$19.6M | −$20.1M | Open → |
| FY20222023-03-31 | $424,028 | +$2.2M | Open → |
| FY20212022-03-31 | −$1.7M | −$1.1M | Open → |
| FY20182019-03-31 | −$676,016 | +$369,813 | Open → |
| FY20172018-03-31 | −$1.0M | +$821,785 | Open → |
| FY20162017-03-31 | −$1.9M | −$1.3M | Open → |
| FY20152016-03-31 | −$520,452 | −$517,203 | Open → |
| FY20142015-03-31 | −$3,249 | +$289,362 | Open → |
| FY20132014-03-31 | −$292,611 | — | Open → |
Income tax expense — Income tax expense is the tax a company charged against profit in its income statement for the year. It is not the same as the cash it handed to tax authorities: deferred tax, provisions and timing differences separate the two, often by billions. The cash figure is a different line in the cash-flow statement.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Income tax expense at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Elite Pharmaceuticals income tax expense |url=https://companiesranked.com/en/company/elite-pharmaceuticals/income-tax-expense |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Elite Pharmaceuticals income tax expense. CompaniesRanked. https://companiesranked.com/en/company/elite-pharmaceuticals/income-tax-expenseBibTeX
@misc{companiesranked-en-company-elite-pharmaceuticals-income-tax-expense-2026,
author = {{CompaniesRanked}},
title = {{Elite Pharmaceuticals income tax expense}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/elite-pharmaceuticals/income-tax-expense}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001493152-26-031070 · June 29, 2026
{{cite web |title=Elite Pharmaceuticals income tax expense — 10-K (0001493152-26-031070) |url=https://www.sec.gov/Archives/edgar/data/1053369/000149315226031070/form10-k.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-06-29}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.